We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > New medicine

News List

AstraZeneca Sells Rights to Alvesco, Omnaris and Zetonna to Covis Pharma americanpharmaceuticalreview
November 10, 2018
AstraZeneca has entered into an agreement with Covis Pharma to sell its rights to the medicines Alvesco (ciclesonide), used for the treatment of persistent asthma, and Omnaris and Zetonna (ciclesonide), used for the treatment of nasal symptoms associated
Fervent Pharmaceuticals to Begin Menopause Therapy Trial americanpharmaceuticalreview
December 29, 2017
Fervent Pharmaceuticals has submitted an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) for FP-101, its proprietary lead drug candidate for treating menopause symptoms, especially hot flashes.